CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,324,753
- in 4 filings, $12.3M under 10b5-1 plans
Net −$12,324,753. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Coyne Terrance P. EVP & CFO | Gift · Class E Ordinary Shares | −18,500 | 1,788,777 | ||
| 2026-08-07 | Legorreta Pablo G. CEO, Chairman of the Board | Gift · LP interests in RPI US Partners 2019, LP | −30,000 | 662,701 | ||
| 2026-08-05 | Urist Marshall EVP, Research & Investments | Grant or award | +8,252 | 8,252 | ||
| 2026-08-05 | Coyne Terrance P. EVP & CFO | Grant or award | +11,002 | 11,002 | ||
| 2026-08-05 | Hite Christopher EVP & Chairman, Partnering | Grant or award | +11,002 | 470,401 | ||
| 2026-08-05 | Legorreta Pablo G. CEO, Chairman of the Board | Grant or award | +65,216 | 1,307,820 | ||
| 2026-07-01 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −9,099 | $55.88 | $508K | 0 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −97,446 | $56.50 | $5.5M | 461,953 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −2,554 | $57.10 | $146K | 459,399 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −29,400 | $56.44 | $1.7M | 40,600 |
| 2026-06-30 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −600 | $57.09 | $34K | 40,000 |
| 2026-06-30 | Bassler Bonnie L Director | Grant or award | +689 | $54.40 | $37K | 79,181 |
| 2026-06-24 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −9,098 | $55.18 | $502K | 9,099 |
| 2026-06-23 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −32,408 | $54.11 | $1.8M | 676,991 |
| 2026-06-23 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −117,592 | $54.47 | $6.4M | 559,399 |
| 2026-06-05 | Engelbert Catherine M. Director | Grant or award | +4,545 | 55,673 | ||
| 2026-06-05 | Ho Carole Director | Grant or award | +4,545 | 4,545 | ||
| 2026-06-05 | Coric Vlad Director | Grant or award | +4,545 | 15,343 | ||
| 2026-06-05 | Bassler Bonnie L Director | Grant or award | +4,545 | 78,492 | ||
| 2026-06-05 | Norden Gregory Director | Grant or award | +4,545 | 196,348 |
Page 2 of 8 · 159 trades